Results 221 to 230 of about 54,072 (237)

Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data: How to Avoid Design Choices That Generate Immortal Time

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Since real‐world data lack information on treatment assignment (usually the only information available is treatment prescription/administration) and early outcomes can happen in advanced cancer, some design choices may introduce immortal time due to selection or due to treatment strategy misclassification.
Xabier Garcia‐Albeniz, Julia Vila‐Guilera, Manuel Zamparini, Helena Oliveres, Vicente Alonso‐Orduna, Jaime Feliu, Ana Fernández‐Montes, Marta Martín‐Richard, Elisa Gálvez‐Munoz, Ana Ruiz‐Casado, Alfonso Yubero‐Esteban, Jorge Aparicio, Julia Alcaide‐Garcia, Javier Gallego Plazas, Carlos Fernandez‐Martos, Rosa Gallego‐Sanchez, Mónica Guillot Morales, Rubén Leno, Francis Esposito, Sandra Lopez‐Prades, Míriam Cuatrecasas, Barbra A. Dickerman, Joan Maurel   +22 more
wiley   +1 more source

[Therapeutic Nursing Support and Psychotherapy in Childhood and Youth Obesity: AEESME's Public Health Approach']. [PDF]

Aten Primaria
Aguilera-Serrano C, Chacón-Cabanillas R, Carretero-Román J, García-Sastre M.   +3 more
europepmc   +1 more source

Allergen Immunotherapy for the Treatment of Eosinophilic Esophagitis. An EAACI Task Force Systematic Review

Clinical and Translational Allergy, Volume 16, Issue 6, June 2026.
ABSTRACT Background Multiple routes of allergen immunotherapy (AIT) are approved for several IgE‐mediated allergic diseases; however, the use of AIT in eosinophilic esophagitis (EoE) remains controversial and is supported by limited evidence. This review, conducted within the frame of an EAACI Task Force, aims to systematically evaluate the use of AIT ...
Martina Votto, Georgios Rentzos, Darío Antolin‐Amerigo, Barbara Rymarczyk, George N. Konstantinou, Adam T. Fox, Antonella Cianferoni, Arzu Bakirtas, Carlo Maria Rossi, Marina Tsoumani, Enrico Heffler, Ingrid Terreehorst, Evangelia C. Apostolidou, Maria Beatrice Biló, Oliver Pfaar, Alfredo J. Lucendo, Georgios K. Nikolopoulos, Constantinos Pitsios   +17 more
wiley   +1 more source

Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA Registry. [PDF]

Ther Adv Gastroenterol
Madero-Velázquez L, de Francisco R, Herreros B, Yagüe C, Bujanda L, Calvet X, Ponferrada A, Aguas M, Rodríguez-Moranta F, Marín-Jiménez I, Catalá L, Gargallo-Pueyo C, Huguet J, Mesonero F, Monfort D, Sierra-Ausín M, Igualada L, Ricart-Gomez E, González-Vivo M, García MJ, Camba AH, Elorza A, Zabalza-San Martín L, Ramos L, Martín-Arranz MD, Ruiz-Núñez I, Martínez-Montiel P, Soto P, Roig C, Molina M, Mañosa M, Alba C, Barreiro-de Acosta M, Gisbert JP, Ramírez de la Piscina P, Lorente R, Zabana Y, Botella B, Riestra S, Belen-Galipienso O, Busquets D, Argüelles F, Pascual JC, Zapater P, Domènech E, Gutiérrez A.   +45 more
europepmc   +1 more source

Standardized Pipeline for Metabolism and Cognition in GO‐DS21 Mouse Model: Investigating Down Syndrome Comorbidities

Current Protocols, Volume 6, Issue 6, June 2026.
Abstract Down syndrome (DS) is the most prevalent form of intellectual disability (ID) globally, with an incidence rate of approximately 1 in 1000 births, affecting over 5 million individuals worldwide. DS is characterized by a genetic profile that predisposes individuals to a range of medical and cognitive conditions, including ID and obesity, which ...
Mohammed Selloum, Patricia da Silva‐Buttkus, Fabrice Riet, Nathalia R. V. Dragano, Lillian Garrett, Hugues Jacobs, Sabine M. Hölter, Nicolas Torquet, Birgit Rathkolb, Loic Lindner, Valerie Gailus‐Durner, Guillaume Pavlovic, Li Chan, Johannes Beckers, Benoit Petit Demoulière, Helmut Fuchs, Elodie Ey, Tania Sorg, Martin Hrabe de Angelis, Yann Herault, the GO‐DS21 Consortium   +20 more
wiley   +1 more source

A Novel Minimally Invasive Porcine Model of Functional Tricuspid Regurgitation. [PDF]

J Cardiovasc Dev Dis
González-Cucharero C, Hernández I, Díez-Mata J, Ramírez-Carracedo R, Saura M, Baéz-Díaz C, Vázquez-López F, Sánchez-Margallo FM, Zamorano JL, Crisóstomo V, Zaragoza C.   +10 more
europepmc   +1 more source

Effectiveness and safety of cenobamate after conversion to monotherapy or dual therapy in real‐world clinical practice

Epileptic Disorders, Volume 28, Issue 3, Page 775-785, June 2026.
Abstract Objective Patients with drug‐resistant epilepsy (DRE) typically take multiple anti‐seizure medications (ASMs) and are at risk of treatment‐related adverse events (AEs). This study assessed the impact of cenobamate monotherapy or dual therapy in patients with drug‐resistant epilepsy.
Álvaro Sánchez‐Guijo Benavente, Guillermina García Martín, Estuardo Daniel Castro Ruiz, Pablo Cabezudo García, Yolanda López Moreno, José Carlos Estévez María, Irene Lorite Fuentes, Sergio Navarro Conti, Raquel Calle Calle, Alejandro Fernández Cabrera, Isabel Ros González, Dulce Campos Blanco, María Isabel Chamorro Muñoz, Pedro Jesús Serrano Castro   +13 more
wiley   +1 more source

A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance. [PDF]

Proc Natl Acad Sci U S A
Liaki V, Barrambana S, Kostopoulou M, Lechuga CG, Zamorano-Dominguez E, Acosta-Gallego D, Morales-Cacho L, Álvarez R, Sun P, Rosas-Perez B, Barrero R, Jiménez-Parrado S, López-García A, San Roman M, López-Gil JC, Drosten M, Sainz B, Musteanu M, Caleiras E, Dusetti N, Poli V, Sánchez-Bueno F, Guerra C, Barbacid M.   +23 more
europepmc   +1 more source

Artificial intelligence and digital health in Colombia: outlook of the most recent advances and future challenges [PDF]

Biomedica
López DM, Osorio JS.
europepmc   +1 more source

Correction: Delgado-Núñez et al. Isorhamnetin: A Nematocidal Flavonoid from <i>Prosopis laevigata</i> Leaves Against <i>Haemonchus contortus</i> Eggs and Larvae. <i>Biomolecules</i> 2020, <i>10</i>, 773. [PDF]

Biomolecules
Delgado-Núñez EJ, Zamilpa A, González-Cortazar M, Olmedo-Juárez A, Cardoso-Taketa A, Sánchez-Mendoza E, Tapia-Maruri D, Salinas-Sánchez DO, Mendoza-de Gives P.   +8 more
europepmc   +1 more source